Literature DB >> 10329717

Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture.

T Mizuno1, M Nakata, H Naiki, M Michikawa, R Wang, C Haass, K Yanagisawa.   

Abstract

Deposition of aggregated amyloid beta-protein (Abeta), a proteolytic cleavage product of the amyloid precursor protein (Abeta ), is a critical step in the development of Alzheimer's disease(Abeta++). However, we are far from understanding the molecular mechanisms underlying the initiation of Abeta polymerization in vivo. Here, we report that a seeding Abeta, which catalyzes the fibrillogenesis of soluble Abeta, is generated from the apically missorted amyloid precursor protein in cultured epithelial cells. Furthermore, the generation of this Abeta depends exclusively on the presence of cholesterol in the cells. Taken together with mass spectrometric analysis of this novel Abeta and our recent study (3), it is suggested that a conformationally altered form of Abeta, which acts as a "seed" for amyloid fibril formation, is generated in intracellular cholesterol-rich microdomains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329717     DOI: 10.1074/jbc.274.21.15110

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.

Authors:  Alexandra M Nicholson; D Nicole Riherd Methner; Adriana Ferreira
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

4.  CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.

Authors:  Alexandra M Nicholson; Adriana Ferreira
Journal:  Cogn Sci (Hauppauge)       Date:  2010-07-01

Review 5.  Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.

Authors:  Nina E Shepardson; Ganesh M Shankar; Dennis J Selkoe
Journal:  Arch Neurol       Date:  2011-10

Review 6.  Alzheimer's disease and cholesterol: the fat connection.

Authors:  Laura Canevari; John B Clark
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

7.  Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway.

Authors:  J L Galbete; T R Martin; E Peressini; P Modena; R Bianchi; G Forloni
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 8.  GM1 Ganglioside: Past Studies and Future Potential.

Authors:  Massimo Aureli; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Gino Toffano; Cynthia Secchieri; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

Review 9.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

10.  Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B).

Authors:  Goar Gevorkian; Alfonso Gonzalez-Noriega; Gonzalo Acero; Jorge Ordoñez; Colette Michalak; Maria Elena Munguia; Tzipe Govezensky; David H Cribbs; Karen Manoutcharian
Journal:  Neurochem Int       Date:  2007-11-12       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.